← Back to Search

Mineral and Electrolyte Replacement

phosphate for Rickets

Phase < 1
Waitlist Available
Led By Clemens Bergwitz, MD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

This trial will look at the effects of different doses and lengths of treatment of a condition called hypophosphatemic rickets with hypercalciuria.

Eligible Conditions
  • Rickets
  • Low Phosphate
  • Hypophosphatemia
  • Hypothalamic Hamartoma Syndrome
  • Hypercalciuria

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fibroblast Growth Factor 23 (FGF23) levels
Parathyroid Hormone (PTH) levels

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Patients with hereditary hypophosphatemic rickets with HHRHExperimental Treatment1 Intervention
Hereditary hypophosphatemic rickets with hypercalciuria (HHRH)
Group II: Patients with X-linked HypophosphatemiaActive Control1 Intervention
Patients with X-linked hypophosphatemia
Group III: 15 Patients with X-linked HypophosphatemiaActive Control1 Intervention
15 Patients with X-linked Hypophosphatemia that will receive phosphate treatment for 30 days.
Group IV: 15 Patients Hereditary hypophosphatemic rickets with HHRHActive Control1 Intervention
15 patients withHereditary hypophosphatemic rickets with hypercalciuria (HHRH) that will receive phosphate treatment for 30 days.

Find a Location

Who is running the clinical trial?

National Center for Advancing Translational Sciences (NCATS)NIH
320 Previous Clinical Trials
401,700 Total Patients Enrolled
1 Trials studying Rickets
30,000 Patients Enrolled for Rickets
Yale UniversityLead Sponsor
1,847 Previous Clinical Trials
2,736,498 Total Patients Enrolled
2 Trials studying Rickets
54 Patients Enrolled for Rickets
Clemens Bergwitz, MDPrincipal InvestigatorYale University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
The Impact of Phosphate Metabolism on Healthy Aging
2019. "The Impact of Phosphate Metabolism on Healthy Aging". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03771105.
~1 spots leftby Aug 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top